BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 7548274)

  • 1. Transduction of genes coding for a histocompatibility (MHC) antigen and for its physiological inducer interferon-gamma in the same cell: efficient MHC expression and inhibition of tumor and metastasis growth.
    Lollini PL; De Giovanni C; Landuzzi L; Nicoletti G; Frabetti F; Cavallo F; Giovarelli M; Forni G; Modica A; Modesti A
    Hum Gene Ther; 1995 Jun; 6(6):743-52. PubMed ID: 7548274
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapy of murine mammary carcinoma metastasis with interferon gamma and MHC gene-transduced tumour cells.
    Nanni P; De Giovanni C; Landuzzi L; Nicoletti G; Frabetti F; Rossi I; Cavallo F; Giovarelli M; Forni G; Lollini PL
    Br J Cancer; 1996 Nov; 74(10):1564-9. PubMed ID: 8932336
    [TBL] [Abstract][Full Text] [Related]  

  • 3. H-2K double transfectants of tumor cells as antimetastatic cellular vaccines in heterozygous recipients. Implications for the T cell repertoire.
    Mandelboim O; Feldman M; Eisenbach L
    J Immunol; 1992 Jun; 148(11):3666-73. PubMed ID: 1588053
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunogenization of a murine T-cell lymphoma via transfection with interferon-gamma.
    Raes G; Geldhof A; Vanden Driessche T; Opdenakker G; Sibille C; De Baetselier P
    Leukemia; 1995 Oct; 9 Suppl 1():S121-7. PubMed ID: 7475304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of two H-2K genes, syngeneic and allogeneic, as a strategy for potentiating immune recognition of tumor cells.
    Mandelboim O; Vadai E; Feldman M; Eisenbach L
    Gene Ther; 1995 Dec; 2(10):757-65. PubMed ID: 8750016
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The immune response elicited by mammary adenocarcinoma cells transduced with interferon-gamma and cytosine deaminase genes cures lung metastases by parental cells.
    Nanni P; De Giovanni C; Nicoletti G; Landuzzi L; Rossi I; Frabetti F; Giovarelli M; Forni G; Cavallo F; Di Carlo E; Musiani P; Lollini PL
    Hum Gene Ther; 1998 Jan; 9(2):217-24. PubMed ID: 9472781
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunological and non-immunological influence of H-2Kb gene transfection on the metastatic ability of B16 melanoma cells.
    De Giovanni C; Palmieri G; Nicoletti G; Landuzzi L; Scotlandi K; Bontadini A; Tazzari PL; Sensi M; Santoni A; Nanni P
    Int J Cancer; 1991 May; 48(2):270-6. PubMed ID: 1902202
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of tumor growth and enhancement of metastasis after transfection of the gamma-interferon gene.
    Lollini PL; Bosco MC; Cavallo F; De Giovanni C; Giovarelli M; Landuzzi L; Musiani P; Modesti A; Nicoletti G; Palmieri G
    Int J Cancer; 1993 Sep; 55(2):320-9. PubMed ID: 8370628
    [TBL] [Abstract][Full Text] [Related]  

  • 9. H-2 antigen expression and sensitivity of BL6 melanoma cells to natural killer cell cytotoxicity.
    Gorelik E; Gunji Y; Herberman RB
    J Immunol; 1988 Mar; 140(6):2096-102. PubMed ID: 3126240
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rejection of K1735 murine melanoma in syngeneic hosts requires expression of MHC class I antigens and either class II antigens or IL-2.
    Chen PW; Ananthaswamy HN
    J Immunol; 1993 Jul; 151(1):244-55. PubMed ID: 8326126
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The expression of CD70 and CD80 by gene-modified tumor cells induces an antitumor response depending on the MHC status.
    Douin-Echinard V; Bornes S; Rochaix P; Tilkin AF; Peron JM; Bonnet J; Favre G; Couderc B
    Cancer Gene Ther; 2000 Dec; 7(12):1543-56. PubMed ID: 11228533
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduced tumorigenicity of murine tumor cells secreting gamma-interferon is due to nonspecific host responses and is unrelated to class I major histocompatibility complex expression.
    Esumi N; Hunt B; Itaya T; Frost P
    Cancer Res; 1991 Feb; 51(4):1185-9. PubMed ID: 1900037
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IFN-alpha 1 gene expression into a metastatic murine adenocarcinoma (TS/A) results in CD8+ T cell-mediated tumor rejection and development of antitumor immunity. Comparative studies with IFN-gamma-producing TS/A cells.
    Ferrantini M; Giovarelli M; Modesti A; Musiani P; Modica A; Venditti M; Peretti E; Lollini PL; Nanni P; Forni G
    J Immunol; 1994 Nov; 153(10):4604-15. PubMed ID: 7963533
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of gene-modified (IL-7, IL-4, and B7) tumor cell vaccines on tumor antigen presentation.
    Cayeux S; Richter G; Noffz G; Dörken B; Blankenstein T
    J Immunol; 1997 Mar; 158(6):2834-41. PubMed ID: 9058819
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation by IFN-gamma of the metastatic ability of murine, human, and H-2-transfected tumor cells.
    Lollini PL; De Giovanni C; Nicoletti G; Scotlandi K; Landuzzi L; Nanni P
    Tumori; 1989 Aug; 75(4):383-8. PubMed ID: 2510384
    [TBL] [Abstract][Full Text] [Related]  

  • 16. H-2Kb antigen expression has no effect on natural killer susceptibility and tumorigenicity of a murine hepatoma.
    Nishimura MI; Stroynowski I; Hood L; Ostrand-Rosenberg S
    J Immunol; 1988 Dec; 141(12):4403-9. PubMed ID: 3264312
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antimetastatic vaccination of tumor-bearing mice with two types of IFN-gamma gene-inserted tumor cells.
    Porgador A; Bannerji R; Watanabe Y; Feldman M; Gilboa E; Eisenbach L
    J Immunol; 1993 Feb; 150(4):1458-70. PubMed ID: 8432988
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Introduction of the interferon gamma gene into mouse T lymphoma cells with low MHC class I-expression results in selective induction of H-2Dk and concomitant enhanced metastasis.
    Geldhof AB; VandenDriessche T; Opdenakker G; De Baetselier P
    Cancer Immunol Immunother; 1996 Jul; 42(6):329-38. PubMed ID: 8830735
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decreased adhesion to endothelial cells and matrix proteins of H-2Kb gene transfected tumour cells.
    Lauri D; De Giovanni C; Biondelli T; Lalli E; Landuzzi L; Facchini A; Nicoletti G; Nanni P; Dejana E; Lollini PL
    Br J Cancer; 1993 Nov; 68(5):862-7. PubMed ID: 7692918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin 12 gene therapy of MHC-negative murine melanoma metastases.
    Nanni P; Rossi I; De Giovanni C; Landuzzi L; Nicoletti G; Stoppacciaro A; Parenza M; Colombo MP; Lollini PL
    Cancer Res; 1998 Mar; 58(6):1225-30. PubMed ID: 9515809
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.